Changeflow GovPing Healthcare & Life Sciences Cell Expansion Vessel Systems and Methods, US20...
Routine Notice Added Final

Cell Expansion Vessel Systems and Methods, US20260109928A1

Email

Summary

USPTO published patent application US20260109928A1 on April 23, 2026, filed December 19, 2025, covering cell expansion vessel systems and methods for cell culture. The application lists inventors Weston Blaine Griffin, Xiaohua Zhang, Reginald Donovan Smith, and Vandana Keskar. The CPC classifications indicate innovations in cell culture equipment, bioreactors, and cell handling systems. This is a publication of a pending application, not a granted patent.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 263 changes logged to date.

What changed

USPTO published patent application US20260109928A1 for cell expansion vessel systems and methods. The application covers systems for introducing cell suspensions into culture vessels, allowing cells to settle on gas-permeable membranes, maintaining constant volume during expansion, and resuspending cells for harvest through drain ports.

Affected parties include biotechnology companies, cell therapy developers, and researchers working with cell culture systems. Patent applications create no immediate compliance obligations but establish prior art that may affect freedom-to-operate assessments for competing technologies in the cell therapy and biomanufacturing space.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

Cell Expansion Vessel Systems and Methods

Application US20260109928A1 Kind: A1 Apr 23, 2026

Inventors

Weston Blaine Griffin, Xiaohua Zhang, Reginald Donovan Smith, Vandana Keskar

Abstract

A method includes introducing a suspension including cells suspended in a cell culture medium through a feed port or a drain port into a cavity of a cell culture vessel, the suspension being in an amount sufficient to cover a gas permeable, liquid impermeable membrane positioned at a bottom of the cell culture vessel, the feed port being disposed through a surface of the cell culture vessel and configured to permit additional cell culture medium into the cavity, and the drain port being disposed through the surface of the cell culture vessel and configured to permit removal of the cells, cell culture medium, and used cell culture medium from the cavity, allowing the cells to settle on the gas permeable, liquid impermeable membrane by gravity, removing the used cell culture medium through the drain port and introducing the additional cell culture medium through the feed port such that a constant volume is maintained in the cell culture vessel until the cells expand to a desired cell density, wherein the removing and introducing are performed subsequent to allowing the cells to settle on the gas permeable, liquid impermeable membrane, resuspending the cells in the cell culture medium in the cell culture vessel, wherein the resuspending is performed after the desired cell density is attained, and removing the resuspended cells and the cell culture medium through the drain port.

CPC Classifications

C12M 29/04 C12M 23/08 C12M 23/24 C12M 25/02 C12M 25/06 C12M 29/18 C12M 29/26 C12M 33/00 C12M 41/46 C12N 5/0636

Filing Date

2025-12-19

Application No.

19427620

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Manufacturers
Industry sector
3254.1 Biotechnology
Activity scope
Patent application filing Biotechnology research
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!